UK Bans Essure While America Still Cashes In
This week both Finland and the UK joined Brasil in discontinuing Essure. By September 1, all sales and distribution of Essure will cease in the UK. However, instead of the manufacturer Bayer admitting that they aren’t selling there anymore because the device is less effective than traditional tubal ligation surgery, is causing thousands of women
Read More
Invokana Lawsuit Schedules Science Day for July
According to a Case Management Order, the U.S. District Court, District of New Jersey will convene Science Day on July 19, 2017, at 9:30 a.m. State court judges presiding over other this Invokana lawsuit and others will be invited to attend. Science Day Science Day is a common proceeding in large, complex litigations. On this
Read More
The Deadly Side Effects of Invokana
Invokana was the first in a new class of drug for Type 2 diabetics. It was supposed to help people easily manage their diabetes without insulin by lowering blood sugar by causing the kidneys to remove sugar from the body via urine. This prevents blood from reabsorbing the sugar. In March 2013, the FDA approved
Read More
Second Xarelto Bellwether Trial Underway
Once again, The Michael Brady Lynch Firm is fighting for pharmaceutical injustice our clients. In a courtroom in New Orleans, a jury will hear evidence this week that the manufacturer Bayer and Johnson & Johnson of the blood thinner Xarelto purposely hid side effects from patients and doctors. This malice led to the unfortunate death
Read More
FDA Reports 30 Deaths and 10,000 Injuries From Essure
The FDA recently updated their ongoing safety review of the birth control device, Essure. In the last two years, the FDA received over 10,000 reports of injuries and 30 deaths from the device. This is just the small amount actually reported to the agency. Statistics have shown that many neglect to report adverse events to
Read More
Researchers Find Melanoma Causing Cell – Implications for Viagra Melanoma Victims
Skin cancer is nothing to take lightly. It is the most common form of cancer in the United States. Melanoma being the deadliest. It begins by invading the melanocytes (pigment-producing cells). The melanocytes are responsible for mole formation. Melanoma will develop from these moles and change the color pigmentation. If caught early with regular skin
Read More
New Study Suggests Xarelto Causes More Bleeding Than Even Pradaxa
A study published in JAMA Internal Medicine suggests Xarelto causes more bleeding than Pradaxa. Researchers found that people using Xarelto may be more likely to have a serious bleeding event than those taking Pradaxa. This could explain why manufacturer, Johnson & Johnson is facing close to 20,000 Xarelto lawsuits. JAMA Study: Xarelto Causes More Bleeding Researchers
Read More
FDA Recalls around 30,000 Abbott-Thoratec’s HeartMate II LVAS Devices
The FDA issued a Class I Recall against HeartMate II Left Ventricle Assist (LVAS) Pocket System Controller manufacturer, Abbott-Thoratec. This is the most serious formal recall since the issue with the device can result in serious injury or death. Regulators are concerned that when switching to the backup system the device can malfunction and thus
Read MoreJohnson & Johnson Shows Zero Remorse
This week Johnson & Johnson petitioned a Missouri state appeals court to dismiss a $72 million verdict. Last year, a jury awarded the settlement to the family of an Alabama woman who claimed the company’s talcum-based hygiene product caused her ovarian cancer. The company argued to a three-judge panel that a lawsuit filed by an
Read More
Invokana Litigation Heading to Trial
Those who trusted the Type 2 diabetes drug, Invokana or Invokamet, but ended up with the deadly side effect of diabetic ketoacidosis are getting their time in court. According to a Case Management Order dated May 1st, the U.S. District Court of New Jersey established a discovery schedule. This schedule will address the selection of
Read More